Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barzanti

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The American Journal of Physiology|October 1, 1996
Histamine activates phospholipase C in human airway epithelial cells via a phorbol ester-sensitive pathwayM Rugolo, F Barzanti, D C Gruenert, et al.
Critical Reviews in Oncology/Hematology|February 13, 2001
In vitro preclinical models for a rational design of chemotherapy combinations in human tumorsW Zoli, L Ricotti, A Tesei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Combined 4-hydroxy-ifosfamide and vinorelbine treatment in established and primary human breast cell culturesL Ricotti, F Barzanti, A Tesei, et al.
Journal of Chemotherapy (Florence, Italy)|December 29, 2000
Lanreotide-induced modulation of 5-fluorouracil or mitomycin C cytotoxicity in human colon cancer cell lines: a preclinical studyA Tesei, L Ricotti, F De Paola, et al.
Journal of Biological Regulators and Homeostatic Agents|June 7, 2000
Correlation between p53 gene mutations and p53 protein accumulation evaluated by different methodologiesD Calistri, F Barzanti, M Dal Susino, et al.
Journal of Biological Regulators and Homeostatic Agents|February 28, 2002
Simultaneous determination of apoptosis and surface antigen expression in tumor adherent cellsF Barzanti, W Zoli, M D Susino, et al.
Breast Cancer Research and Treatment|April 1, 1997
Establishment and characterization of two new cell lines derived from human metastatic breast carcinomasW Zoli, L Roncuzzi, N Zini, et al.
International Journal of Cancer|February 6, 1999
Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell linesW Zoli, L Ricotti, F Barzanti, et al.
British Journal of Cancer|November 26, 1999
Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancerW Zoli, L Ricotti, M Dal Susino, et al.
Oncology|March 27, 2002
Flow-cytometric determination of tumor cells in lymph nodesW Zoli, F Barzanti, M Dal Susino, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The American Journal of Physiology|October 1, 1996
Histamine activates phospholipase C in human airway epithelial cells via a phorbol ester-sensitive pathwayM Rugolo, F Barzanti, D C Gruenert, et al.
Critical Reviews in Oncology/Hematology|February 13, 2001
In vitro preclinical models for a rational design of chemotherapy combinations in human tumorsW Zoli, L Ricotti, A Tesei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Combined 4-hydroxy-ifosfamide and vinorelbine treatment in established and primary human breast cell culturesL Ricotti, F Barzanti, A Tesei, et al.
Journal of Chemotherapy (Florence, Italy)|December 29, 2000
Lanreotide-induced modulation of 5-fluorouracil or mitomycin C cytotoxicity in human colon cancer cell lines: a preclinical studyA Tesei, L Ricotti, F De Paola, et al.
Journal of Biological Regulators and Homeostatic Agents|June 7, 2000
Correlation between p53 gene mutations and p53 protein accumulation evaluated by different methodologiesD Calistri, F Barzanti, M Dal Susino, et al.
Journal of Biological Regulators and Homeostatic Agents|February 28, 2002
Simultaneous determination of apoptosis and surface antigen expression in tumor adherent cellsF Barzanti, W Zoli, M D Susino, et al.
Breast Cancer Research and Treatment|April 1, 1997
Establishment and characterization of two new cell lines derived from human metastatic breast carcinomasW Zoli, L Roncuzzi, N Zini, et al.
International Journal of Cancer|February 6, 1999
Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell linesW Zoli, L Ricotti, F Barzanti, et al.
British Journal of Cancer|November 26, 1999
Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancerW Zoli, L Ricotti, M Dal Susino, et al.
Oncology|March 27, 2002
Flow-cytometric determination of tumor cells in lymph nodesW Zoli, F Barzanti, M Dal Susino, et al.
Pageof 2